ArticlePDF Available

Vaginal Electrical Impedance Detects the Fertile Window in Healthy Women: a Pilot Study

Authors:
  • Instituto Jalisciense de Cancerologia / Universidad de Guadalajara

Abstract and Figures

This work analyzes the electrical impedance (EI) measurement of cervical mucus (CM) using a device to determine the fertile window. In this prospective and longitudinal study, fourteen healthy women aged 18 to 44 were enrolled to evaluate three menstrual cycles. EI was measured through a medical device inserted into the vagina for two minutes daily. Patients were monitored by urine luteinizing hormone (LH) strip, blood collection, and vaginal ultrasound to visualize the dominant follicle. Finally, the predictive EI capacity was validated by the receiver operating characteristic (ROC) of anovulatory vs. ovulatory impedances. The peak of LH was 35.7 (±4.5) mUI/ml and the dominant follicle size was 15.45 mm (±0.559). There were statistical differences in EI measurements between the follicular and luteal phases vs. the ovulation phase (p<0.0361 and p<0.0160). After data normalization, an area under the ROC curve (AUC) of 0.713 (P value= 0.0253), a Youden J index of 0.4545Ω, a sensitivity of 63.6%, and a specificity of 81.8% were found. Low EI in the ovulatory period belongs to the LH ovulatory peak and follicular release. EI can be used for ovulation monitoring, birth control, or promoting pregnancy as a safe and innocuous method.
Content may be subject to copyright.
VOL. 43 | NO. 3 | SEPTEMBER - DECEMBER 2022 | PP 6-14
RESEARCH ARTICLE
E-LOCATION ID: 1290
dx.doi.org/10.17488/RMIB.43.3.1
ib
Vaginal Electrical Impedance Detects the Fertile Window in Healthy
Women: a Pilot Study
La Impedancia Eléctrica Vaginal Detecta la Ventana Fértil en Mujeres Sanas: un Estudio Piloto
José Alfonso Cruz-Ramos1 , Joe Klepich2 A, Martha Eloisa Ramos-Márquez1 A, Gerardo García-Gil3 A,
Luis Ilich Vladimir Guerrero-Linares3 A, Gabriela del Carmen López-Armas3 A B
1Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud - México
2School of Informatics, master's in Information and Data Science, University of California, Berkeley - United States
3Centro de Enseñanza Técnica Industrial, Guadalajara, Jalisco - México
ABSTRACT
This work analyzes the electrical impedance (EI) measurement of cervical mucus (CM) using a device to determine
the fertile window. In this prospective and longitudinal study, fourteen healthy women aged 18 to 44 were enrolled
to evaluate three menstrual cycles. EI was measured through a medical device inserted into the vagina for two min-
utes daily. Patients were monitored by urine luteinizing hormone (LH) strip, blood collection, and vaginal ultrasound
to visualize the dominant follicle. Finally, the predictive EI capacity was validated by the receiver operating charac-
teristic (ROC) of anovulatory vs. ovulatory impedances. The peak of LH was 35.7 (±4.5) mUI/ml and the dominant
follicle size was 15.45 mm (±0.559). There were statistical dierences in EI measurements between the follicular
and luteal phases vs. the ovulation phase (p<0.0361 and p<0.0160). After data normalization, an area under the
ROC curve (AUC) of 0.713 (P value= 0.0253), a Youden J index of 0.4545Ω, a sensitivity of 63.6%, and a specicity of
81.8% were found. Low EI in the ovulatory period belongs to the LH ovulatory peak and follicular release. EI can be
used for ovulation monitoring, birth control, or promoting pregnancy as a safe and innocuous method.
KEYWORDS: Electrical impedance, cervical mucus, ovulation, luteinizing hormone
REVISTA MEXICANA DE INGENIERÍA BIOMÉDICA | VOL. 43 | NO. 3 | SEPTEMBER - DECEMBER 2022
7
RESUMEN
Este trabajo analiza la medición de la impedancia eléctrica (IE) del moco cervical (MC) mediante un dispositivo para
determinar la ventana fértil. En este estudio prospectivo y longitudinal, se incluyeron 14 mujeres sanas de 18 a 44
años para evaluar tres ciclos menstruales. La IE se midió a través de un dispositivo médico colocado en la vagina du-
rante dos minutos diarios. Las pacientes fueron monitoreadas con una tira de hormona luteinizante (LH) en orina, re-
colección de sangre y ultrasonido vaginal para visualizar el folículo dominante. Finalmente, la capacidad predictiva
de IE fue validada por la curva ROC (receiver operating characteristic) de impedancias anovulatorias vs. ovulatorias.
El pico de LH fue de 35.7(±4.5) mUI/ml; el folículo de tamaño dominante fue de 15.45 mm (±0.559). Se encontraron
diferencias estadísticas para la medición de la IE de las fases folicular y lútea versus la fase de ovulación (p<0.0361
y p<0.0160). Después de la normalización de los datos, se encontró un área bajo la curva ROC (AUC) de 0.713 (valor
de P = 0.0253), un índice de Youden J de 0.4545 Ω, sensibilidad del 63.6 % y especicidad del 81.8 %. La IE baja en el
período ovulatorio que pertenece al pico ovulatorio de LH y liberación folicular. La IE se puede utilizar para el control
de la ovulación, el control de la natalidad o la promoción del embarazo como método seguro e inocuo.
PALABRAS CLAVE: Impedancia eléctrica, moco cervical, ovulación, hormona luteinizante
Corresponding author
TO: Gabriela del Carmen López-Armas
INSTITUTION: Centro de Enseñanza Técnica Industrial
ADDRESS: Calle Nueva Escocia #1885, Col. Providencia
5ta. Sección, C. P. 44638, Guadalajara, Jalisco, México
CORREO ELECTRÓNICO: glopez@ceti.mx
Received:
20 June 2022
Accepted:
18 August 2022
José Alfonso Cruz-Ramos et al. Vaginal Electrical Impe dance Detects the Fe rtile Window in Healthy Wom en: a Pilot Study 8
INTRODUCTION
Cervical mucus CM is produced by secretory cells in
endocervical glands and discharged into the endocervi-
cal conduct. CM is composed mostly of water up to 90%;
the rest consists of mucins that confer viscoelastic gel
properties, amino acids, ions, cholesterol, lipids, glucose,
polysaccharides, soluble proteins, and enzymes 1 2 3. In
normal conditions, the secretion of CM changes quantita-
tively and qualitatively through the hormonal cycle stage.
The secretion of CM depends on the hormonal cycle:
women produce 20-60 mg of CM per day until they
reach approximately 600 mg in the ovulation period, a
crucial change for the transport of spermatozoa to the
mature follicle 4. This pattern occurs in fertile women,
but in infertile females, the panorama is quite different
5. Several hormones participate in ovulation: gonado-
tropin-releasing hormone GnRH acting from the
hypothalamus; follicle-stimulating hormone FSH and
luteinizing hormone LH secreted by the anterior pitu-
itary gland, and estradiol and progesterone produced in
the ovary. In the initial phase of the menstrual cycle,
the estrogens stimulate FSH production and release; by
positive feedback, FSH increases during the irst half of
the cycle. In the middle of the cycle, the rise in FSH and
LH triggers ovulation 6. Later, the surge in FSH and LH
generates negative feedback in gonadotropin secretion,
and the hormone levels fall during the second half of
the cycle. If pregnancy is absent, the secretion of estro-
gens and progesterone starts to diminish after ovula-
tion, and menstrual bleeding occurs. Hormonal fluctu-
ations throughout the menstrual cycle are the main
factor influencing ovulation 7 .
Ovulation is currently detected through blood tests and
intravaginal ultrasound to identify the dominant ovar-
ian follicle 8. EI has been widely used in biological appli-
cations since 1925, with signiicant advances during the
past one hundred years 9 1 0 1 1; actually, it may be a
more reliable and convenient detection tool. Although
EI has been used to assess cervical neoplasia or cervical
ripening in pregnant and non-pregnant women 12 13 14 ,
it has barely been applied to detect ovulation 15 16 17 18
19  20. Hence, this work aims to determine the ovulation
window via measuring the impedance of CM by a mini-
mum invasive EI device. Our principal objective was to
assess the feasibility of correlating impedance values
with serum concentrations of estradiol, FSH, LH, pro-
gesterone, prolactin, and total testosterone, as well as
intravaginal ultrasound, to observe and measure ovar-
ian follicle release. All laboratory tests were performed
according to each patient menstrual cycle to precisely
detect the ovulation period or fertile window.
MATERIALS AND METHODS
This pilot, prospective, longitudinal protocol aimed to
identify variations of EI in cervical mucus at different
phases of the reproductive cycle. Fourteen healthy
women aged from 18 to 44 years and with a complete
gynecological-obstetric history were included. Each
participant provided written consent for blood proce-
dure, intravaginal ultrasound, and device use. Internal
Committee for Research and Follow-up of Research
Projects CIESPI of the Technical Industrial Teaching
Center approved the study with the number PI-07-18-
20. All selected participants had a normal hormonal
proile, did not use hormonal contraceptives, DIU dis-
positive, or any vaginal treatment such as lubricants,
creams, or ointments for at least two months, and were
willing to take protective measures during sexual inter-
course. All women had regular pap smear reports.
During the study, two participants were excluded by a
hormonal disturbance in the second cycle and another
one for pregnancy, staying only eleven. With prior train-
ing for device and mobile app use, all women auto-mea-
sured impedance with the Kegg device for two minutes
daily in the morning. Measurements were made for
three consecutive menstrual cycles starting the irst
day after bleeding in each cycle. The hormonal activity
was monitored in urine, blood samples, and ovulation
via vaginal ultrasound Figure 1- c. For the correct use
of the device, the dorsal position was obligatory.
REVISTA MEXICANA DE INGENIERÍA BIOMÉDICA | VOL. 43 | NO. 3 | SEPTEMBER - DECEMBER 2022
9
Electric impedance measurement
We used kegg device, model K-1 Lady Technologies,
Inc., San Francisco, CA, powered by a 50mAh battery
that includes an electronic impedance circuit made
with gold-plated stainless-steel electrodes, a main-
board to transfer all information via Bluetooth to
mobile application Android and IOS and a vibration
motor for patient feedback. The device is covered with
medical-grade silicone for safety and comfortability
and has been thoroughly tested according to IEC/ISO
standards Figure 1 a-b. For proper usage, the device
is inserted into the vagina to reach the cervical fluid
pool.
Urine and blood sample hormonal
measurements
On the same day the patients started using the EI
device, they tested their LH concentration with the
Clearblue® strip S.P.D., Swiss Precision Diagnostics
GmbH, Geneve, Switzerland on the irst-morning
urine daily. Once the strip test was positive, blood was
collected by a venous puncture for hormonal determi-
nation of LH, FSH, estradiol, prolactin, and total tes-
tosterone employing immunoquimioluminiscence
Ortho, Vitros 5600, Inc. California, USA. Progesterone
was determined in another blood sample by the same
methodology on day 21 of each cycle.
Vaginal ultrasound
The following day after the positive LH strip, the
woman underwent a vaginal ultrasound SonoAceR3,
Samsung Health Care. Seul, South Korea to verify the
amount and size of follicles in both ovaries.
Characteristic of EI device
The impedance measurement of the kegg device is
based on a balanced bridge whose voltage is read by
the microprocessor ADC. The processor generates a 1
FIGU RE 1. (a) KeggTM device for EI measurement of CM. (b) The mobile application data register. (c) Timeline. Arrow 1.
All subjects must finish vaginal bleeding to start measuring impedance. Arrow 2. All participants began to use the LH strip
until getting a positive result and continued using the device. Arrow 3. Serum quantification of hormones in the blood once
positive urine strip: LH, FSH, Estrogen, total testosterone, and prolactin. Vaginal ultrasound performed within 24 to 48
hours after LH peak. Arrow 4. Serum quantification of progesterone. This scheme was repeated for three menstrual cycles.
José Alfonso Cruz-Ramos et al. Vaginal Electrical Impe dance Detects the Fe rtile Window in Healthy Wom en: a Pilot Study 10
kHz signal at a known voltage which is used to excites
one electrode called the tip, the voltage is then read
on the other electrode called the ring through an
op-amp. This procedure is then reversed, whereby the
second electrode is excited and read by the irst. The
processor performs a calculation based on the known
values of the other legs of the bridge, and a reference
value excitation voltage is then established to deter-
mine the resistance. The measurement is made multi-
ple times to create a sample of set of 50 readings which
is then averaged for a inal impedance value.
The communication process is activated when the
device receives a command from the mobile app via
Bluetooth; ifty readings are required during a single
measurement session. These readings are transferred
to an Android mobile app via Bluetooth Low Energy;
then, the data are saved on the cloud and processed to
determine which readings fall within the iftieth per-
centile and calculate a median value labeled as the
inal impedance value. These values are entered into
the database for each user's session. The Bluetooth is
turned off during the actual measurement process.
Statistical Analysis
Data analysis was carried out using GraphPad Prism LLC
version 8.01 software San Diego, CA and Medcalc soft-
ware Ltd Ostend, Belgium. Results are presented as
means or medians. The raw impedance values of each
phase were compared between them and to those of the
other phases in the same woman and other subjects' val-
ues via the Mann-Whitney U test with Holm-Sidak cor-
rection and an alpha error of 0.05. The level of signii-
cance was set at P <0.05. Data were normalized as follows:
The means of the impedance values of the follicular
Equation 1 FOL and luteal Equation 2 LUT phases of
each cycle were obtained with the following formula:
1
!"# =$+ %+ &
#'( =$+ %+ &
!"# = !"#
#'(  = #'(
)*+,- = $)*+,- )*+,-
This means the impedance value of the day of ovula-
tion Impov LH peak of the corresponding cycle was
subtracted from Equations 3 and 4. The ovulation
impedance values of 3 cycles were added, and the mean
was obtained, which was subtracted from each individ-
ual ovulatory impedance measurement. Equation 5.
With these values, multiple comparisons were made
using the Friedman test and the ROC curve to compare
the ovulatory phase against non-ovulatory phases
luteal and follicular.
RESULTS AND DISCUSSION
No participants reported any injury or collateral effect
using the device to measure impedance in cervical dis-
charge or discomfort by venipuncture for blood tests.
Subjects' metrics
Table 1 describes the mean age and standard devia-
tion SD of the eleven participants at the beginning of
the study, as well as blood values of LH, FSH, estradiol,
prolactin, and total testosterone taken on ovulation
day; only progesterone content was measured on day
21st of each menstrual cycle. Finally, to verify the
ovulation, we also perform ultrasonography 24 to 48
hours after LH serum peak to visualize follicle size and
number Figure 2.
CM raw impedance values
In total, there were 676 impedance measurements
from cervical discharge from eleven participants. In
Figure 3, we divided the menstrual cycle into three
2
!"# =$+ %+ &
#'( =$+ %+ &
!"# = !"#
#'(  = #'(
)*+,- = $)*+,- )*+,-
3
!"# =$+ %+ &
#'( =$+ %+ &
!"# = !"#
#'(  = #'(
)*+,- = $)*+,- )*+,-
4
!"# =$+ %+ &
#'( =$+ %+ &
!"# = !"#
#'(  = #'(
)*+,- = $)*+,- )*+,-
5
!"# =$+ %+ &
#'( =$+ %+ &
!"# = !"#
#'(  = #'(
)*+,- = $)*+,- )*+,-
REVISTA MEXICANA DE INGENIERÍA BIOMÉDICA | VOL. 43 | NO. 3 | SEPTEMBER - DECEMBER 2022
11
phases: follicular, ovulatory LH peak, and luteal. Our
results show that the difference between follicular and
ovulatory phases were statistically signiicant in imped-
ance measurements median 349.1Ω, and median
311.8Ω, P value= <0.0361 concerning the luteal phase
vs. ovulatory phase median 350.3Ω, and median
311.8Ω, P value= <0.016. Finally, we performed Holm-
FIGU RE 4. Box and whisker plot. Impedance normalized
data of follicular, ovulation, and luteal phases. (*) Statistical
differences were found for the impedance measurement
between all phases (P < 0.0435)—Friedman test.
Sidak correction with an alpha of 0.05 for follicular and
luteal phase comparations against the ovulation phase
adjusted P value= <0.03 and adjusted P value= <0.02.
CM normalized impedance values
After data normalization, the Friedman test yielded a
value of P = <0.0435 Figure 4.
FIGU RE 3. Box and whisker plot. Impedance raw
measure of follicular, ovulation, and luteal phases. (*)
Statistical differences were found in the impedance
measurement of the follicular phase. U de Mann test.
FIGU RE 2. Vaginal ultrasound of one patient.
Blue marks signal the dominant follicle of 1.95 cm.
The yellow and purple marks represent the ovarian
width and length in centimeters.
TAB LE 1 . Characteristics of the study subjects.
Table 1
Parameters
Values
Total participants (n)
11
Age (years)
30.6(±8.2)
LH (mUI/ml)
35.7 (±4.5)
Estradiol (pg/ml)
179.3 (±14.2)
Prolactin (ng/ml)
22.60 (±1.93)
Total Testosterone (ng/ml)
0.4109 (±0.025)
José Alfonso Cruz-Ramos et al. Vaginal Electrical Impe dance Detects the Fe rtile Window in Healthy Wom en: a Pilot Study 12
FIGURE 5. ROC curves from normalized data of
impedance measurements of the non-ovulation and
ovulation (LH peak day) periods (p value= <0.0253).
To evaluate the device as a valuable method to distin-
guish the ovulation phase from follicular and luteal
phases of the menstrual cycle, we obtained a receiver
operating characteristic ROC curve under bootstrap
conidence interval 1000 iterations; random number
seed: 978, an area under the ROC curve AUC of 0.713
value of p = <0.0253, and a Youden index J of 0.4545
with a sensitivity of 63.64% and speciicity of 81.82%
Figure 5. With these impedance measurements, we
can discriminate between no ovulation period follicular
and luteal phases and ovulation period LH peak day.
This study describes the application of electrical
impedance measurement to investigate conductivity
changes in CM during the menstrual cycle in healthy
women of reproductive age. Our results revealed a lower
impedance during the ovulatory phase compared with
the follicular and luteal phases. It is well known that pH
changes in CM play a pivotal role in sperm survival since
during the ovulation period, the mucus becomes less
acidic with a nearly neutral pH, and sperm is thus pro-
tected, leading to changes in electrical impedance 2 1.
In this sense, some research has monitored the day-
to-day changes in CM by EI devices. Previous reports
measured salivary or vaginal electrical resistance SER
or VER with a CUE Fertility Monitor. In general, results
show that the peak in LH occurred 4 to 5 days after the
peak measurement in SER, and this had a strong posi-
tive correlation r = 0.94 with the urinary LH surge. As
for VER values, these diminished along with the pre-
ovulatory phase from day -3 until day 0. In this report,
the VER mean at day 0 correlated with the LH surge;
consequently, the nadir was the lowest value on the
CUE Fertility Monitor. Moreno, et al. 13. concluded that
CUE Fertility Monitor has potential for use in natural
family planning NFP. In contrast, a prospective study
on the reliability of the CUE Fertility Monitor 22 that
analyzed sixteen cycles with signals i.e., SER and
VER for the beginning and the end of the fertile
period, could not ind signals in two cycles; therefore,
the researchers did not recommend the CUE Fertility
Monitor utilizing the current algorithm for NFP.
In this work, the EI device was used only once a day
to measure CM. The main objective was to simplify the
daily CM evaluation making it practical and comfort-
able for women. The results of this study indicate a low
impedance value coincident with the LH peak and the
appearance of the dominant follicle, as seen by ultra-
sonography. However, several factors mentioned
below in order of importance can affect the imped-
ances recorded by the device and should be considered
by the end-user. First, end-users must follow the man-
ufacturer's instructions for the Kegg device for two
complete ovulatory cycles.
The methodology carried out in this study provides
enough data to the APP for analysis. Second, it is nec-
essary to constantly monitor the LH in urine or serum
to determine a correlation between the impedance
values obtained in the irst three months when the LH
test is positive. The observation of the LH peak and the
impedance value is fundamental because each woman
has her own hormonal rhythms that influence the
composition of the mucus in the different phases,
there are ultrastructural changes such as the increase
REVISTA MEXICANA DE INGENIERÍA BIOMÉDICA | VOL. 43 | NO. 3 | SEPTEMBER - DECEMBER 2022
13
in pore size of the network of ibers that make up the
mucus during the ovulatory phase that allows a greater
flow of substances producing variations in resistivity
and conductance 23. Another factor is the water con-
tent of the mucus, which reaches up to 99% during
ovulation, which has an impact on the decrease in
impedance in this phase, as opposed to the follicular
and luteal phases where the water content is 90 to
95%. Finally, mucus content and density may also
have an influence, as there are noticeable changes in
the follicular phase, with cervical mucus being more
abundant and dense in the luteal phase compared to
the ovulatory phase 2 4. This last property depends on
hydration, electrolyte content, exercise routine, nutri-
tional habits, age, some vaginal infections, stressful
conditions, etc. So, each woman needs to learn to
know her hormonal levels and observe in time how
they can affect CM production 25. Third, in this study,
users were asked to use protection in all sexual encoun-
ters to avoid direct contact of the device with the
semen, as this could modify the impedance value.
Once the proper cervical mucus values are gained, the
recommendation is to allow 10-12 hours between the
sexual encounter and the impedance measurement.
CONCLUSIONS
This study shows that the kegg device, model K-1,
helps to identify the LH ovulatory peak. Indeed, serum
and urinary increases of LH, together with the ultraso-
nographic documentation of a dominant follicle,
detect a woman's fertile window with a sensitivity of
63.6% and speciicity of 81.8%. Measurement of CM
electric impedance with the Kegg device is more reli-
able than daily monitoring of urinary LH test alone,
making this method cost-effective along with the
ease-of-use beneits. Further studies exploring differ-
ent disorders polycystic ovary syndrome, endometri-
osis, hyperprolactinemia, premature ovarian failure,
or imbalance in thyroid hormone that can affect the
sensitivity and speciicity of EI ovulation values are
required.
ETHICAL STATEMENT
This study followed the ethical principles regarding
human experimentation proposed by the Helsinki dec-
laration; all women were informed about the proce-
dures, risks, and beneits to obtain the written consent
of voluntary participation. The protocol was approved
by the Internal Committee for Research and Follow-up
of Research Projects CIESPI of the Tech nical Industrial
Teaching Center with the number PI-07-18-20.
CONFLICT OF INTEREST
Lady Technologies, Inc supported this project.
ACKNOWLEDGMENT
Despite the health contingency, we are deeply grate-
ful to each of the women who participated in this study
and the health personnel of the different institutions.
Also, we want to thank MD. Ma. de la Paz Jacinto-
Orozco our OB/GYN of the protocol, Engr. Mario
Antonio Mercado-Cisneros for all protocols communi-
cation between KEGG device and APP and Dr. Horacio
Rivera-Ramírez for his review of the manuscript.
AUTHOR CONTRIBUTIONS
J.A.C.R. performed formal analysis, carried out mathemat-
ical and statistical methods for the analysis, participated in
the writi ng, reviewing, and editing t he different states of the
manuscript. J.K. oversaw the development of the project,
obtained funding and resources, designed the clinical pro-
tocol, carried out formal analysis, and developed mathe-
matical, statistical and computational analyses. M.E.M.R.
participated in the writing reviewing and editing of the
manuscript at different stages, pre and post publication.
G.G.G in charge of data curation. L.I.V.G.L. designed the
methodology, carried out experiments collected data and
evidence. G.C.L.A. conceptualization of the project’s objec-
tives and goals, designed the methodology, carried out sta-
tistical analyses oversaw the general project, participated in
the writing of the initial manuscript, carried out and partic-
ipated in the translation to English language. All authors
reviewed and approved the inal version of the manuscript.
REVISTA MEXICANA DE INGENIERÍA BIOMÉDICA | VOL. 43 | NO. 3 | SEPTEMBER - DECEMBER 2022
14
REFERENCES
[1] Curlin M, Bursac D. Cervical mucus from biochemical structure to
clinical implications. Front Biosci Schol Ed Internet.
2013;52:507–515. Ava ilable from: https://doi.org/10.2741/S386
[2] Daunter B, Counsilman C. Cervical mucus: Its structure and
possible biological functions. Europ J Obstet Gynecol Reprod Biol
Internet. 1980;103:141-161. Available from:
https://doi.org/10.1016/0028-2243(80)90056-8
[3] Nicosia SV. Physiology of Cerv ical Mucus Productionle. Semin
Reprod Med Internet. 1986;44:313–321. Available from:
https://www.thieme- connect.de/products/ejournals/
ab st ra ct/10.1055/s-20 07-102 2511
[4] Dubey V, Mythirayee S, Tiwari RK, Gaharwar U, et al. Cervical
Mucus Helps in the Fertilization. World J Pharm Pharm Sci
Internet. 2016;510:242-250 Avalaible from:
https://www.researchgate.net/publication/316681786_CERVICAL_
MUCUS_HELPS_IN_THE_FERTILIZATION
[5] Nakano FY, Leão R de BF, Esteves SC. Insights into the role of
cervical mucus and vaginal pH in unexplained infertility.
MedicalExpress Internet. 2015;22: 1-8. Available from:
https://www.scielo.br/j/medical/a/qjRg5mV765Dvs5tYjCtBwyC/?form
at=pdf&lang= en
[6] Fehring RJ. Accuracy of the peak day of cervical mucus as a
biological marker of fertility. Contraception Internet.
2002;664:231–235. Avai lable f rom:
https://doi.org/10.1016/S0010-7824(02)00355-4
[7] Murcia-Lora JM, Esparza-Encina ML. The Fertile Window and
Biomarkers: A Review and A nalysis of Normal Ovulation Cycles.
Pers Bioet Inter net. 2011;152:149-165. Available from:
http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0123-
31222011000200004&lng=en
[8] Abbara A, Vuong LN, Ho VNA, Clarke SA, et al. Follicle Size on Day
of Trigger Most Likely to Yield a Mature Oocyte. Front Endocrinol
Internet. 2018;9:193. Available from:
https://doi.org/10.3389/fendo.2018.0 0193
[9] Randviir EP, Banks CE. Electrochemical impedance spectroscopy:
An overview of bioanalytical applications. Anal Methods
Internet. 2013;5:1098-1115. Available from:
https://doi.org/10.1039/C3AY26476A
[10] Řezáč P. Potential applications of electrical impedance techniques
in female mammalian reproduction. Theriogenology Internet.
2008;701:1-14. Available from:
https://doi.org/10.1016/j.theriogenology.2008.03.001
[11] Walker DC, Brown BH, Smallwood RH,Hose DR, et al. Modelled
current distribution in cervical squamous tissue. Physiol Meas
Internet. 2002;231:159. Available from:
https://do i.o rg/10.1088/0967-3334/23/1/315
[12] Albrecht BH, Fernando RS, Regas J, Betz G, et al. A new method for
predicting and conirming ovulation. Fertil Steril Internet.
1985;442:200-205. Available from:
https://doi.o rg/10.1016/S0015- 0282(16)48736-4
[13] Moreno JE, Khan-Dawood FS, Goldzieher JW. Natural family
planning: Suitability of the CUETM method for deining the time of
ovulation. Contraception Internet. 1997;554:233-237. Available
from: https://doi.org/10.1016/S0010-7824(97)00007-3
[14] Moreno JE, Weitzman GA, Doody MC, Gibbons WE, et al. Temporal
relation of ovulation to salivary and vaginal electrical resistance
patterns: Implications for natural family planning. Contraception
Internet. 1988;384:407-418. Available from:
https://doi.org/10.1016/0010-7824(88)90082-0
[15] Brown BH, Milnes P, Abdul S, Tidy JA. Detection of cervical
intraepithelial neoplasia using impedance spectroscopy: A
prospective study. BJOG Internet. 2005;1126:802-806. Available
from: ht tps://doi.o rg/10.1111/j.1471-0528.2004.00530.x
[16] Brown BH, Tidy JA, Boston K, Blackett A, et al. Relation between
tissue structure and imposed electrical current flow in cervical
neoplasia. Lancet Internet. 2000;3559207:892-895. Available
from: ht tps://doi.o rg/10.1016/S0140-6736(99)09095-9
[17] Gandhi SV, Walker DC, Brown BH, A numba DO. Comparison of
human uterine cervical electrical impedance measurements
derived using two tetrapolar probes of different sizes. Biomed Eng
Online Internet. 2006;5:62. Available from:
https://doi.or g/10.1186/1475-925X-5-62
[18] Gandhi SV, Walker D, Milnes P, Mukherjee S, et al. Electrical
impedance spectroscopy of the cerv ix in non-pregnant and
pregnant women. Eur J Obstet Gynecol Reprod Biol Internet.
2006;1292:145-149. Available from:
https://doi.org/10.1016/j.ejogrb.2005.12.029
[19] Jokhi RP, Ghule VV, Brown BH, Anumba DO. Reproducibility and
repeatability of measuring the electrical impedance of the
pregnant human cervix-the effect of probe size and applied
pressure. Biomed Eng Online Internet. 2009;8:10. Available from:
https://doi.org/10.1186/1475-925X-8-10
[20] Saito TK de S, Pedriali RA, Gabella CM, Chaves Junior M, et al.
Preliminary results of cervical impedance measurements. Res
Biomed Eng Internet. 2018;3402:110-114. Avalaible from:
https://doi.org/10.1590/2446-4740.05617
[21] Timing of ovulation based on vaginal pH by Gorodeski GI, Liu CC.
2008, Mar. 20. Patent 11/574279 Internet. Available from:
https://uspto.report/patent/app/20080071190
[22] Freundl G, Bremme M, Frank-Herrmann P, Godehardt E, et al. The
CUE fertility monitor compared to ultrasound and LH peak
measurements for fertile time ovulation detection. Adv Contracept
Internet. 1996;12:111-121. Available from:
https://doi.org/10.10 07/BF01849632
[23] Vigil P, Cortés ME, Carrera B, Hauyón R, et al. El moco cervical en
la isiología reproductiva. In: Guzmán E, Croxatto H, Lalonde A
eds. Cervical Mucus in Human Reproduction.
Copenhague:Scriptor; 2014. 325-334p.
[24] Faes TJC, van der Meij HA, de Munck JC, Heethaar RM. The electric
resistivity of human tissues 100 Hz–10 MHz: a meta-analysis of
review studies. Physiol Meas Internet. 1999;20:R1. Available
from: ht tps://doi.o rg/10.1088/0967-3334/20/4/201
[25] Gould KG, Ansari AH. Electrolyte interactions in cer vical mucus
and their relationship to circulating hormone levels.
Contraception. 1981; Available from:
https://doi.org/10.1016/0010-7824(81)90078-0
Article
Comprehensive Summary Deep‐tissue physiological signals are critical for accurate disease diagnosis. Current clinical equipment, however, often falls short of enabling continuous, long‐term monitoring. Wearable and implantable flexible electronics offer a promising avenue for addressing this limitation, allowing in vivo signal collection and paving the way for early diagnosis and personalized treatment. A major challenge lies in ensuring that these devices seamlessly integrate with the diverse physiological microenvironments throughout the human body. Mechanoadaptive bioelectronics is emerging as a key solution to optimize signal acquisition and device robustness. This review provides a comprehensive overview of the physiological characteristics of various organs and the types of signals they generate. Furthermore, it explores recent advancements in mechanoadaptive bioelectronics, systematically categorizes their strategies, and underscores their potential to revolutionize healthcare. Finally, we delve into the ongoing challenges in this field and highlight promising directions to advance the adaptability of bioelectronics further. Key Scientists In 2017, researchers developed an ionic skin with enhanced mechanical compatibility through strain‐hardening properties. [1] Three years later, a neural interface platform called the adaptive self‐healing electronic epineurium (A‐SEE) was reported. [2] This platform minimized stress on neural tissue by dynamically relaxing stress. In 2021, an adaptive hydrogel hybrid probe was developed for long‐term tracking of isolated neuroelectric activity, optogenetics, and behavioral studies of neural circuits. This probe also utilized hydration‐induced softening to minimize the foreign body response. [3] In the same year, a shape‐adaptive imager with a Kirigami design was proposed. [4] In the following year, a morphing electronic (MorphE) device was reported, which exhibited attractive viscoelasticity and minimal stress on the growing nerve during long‐term implantation. [5] In 2023, a standardized tissue‐electronic interface was developed, which can be implanted with minimally invasive cardiac procedures on a rapidly beating heart. [6] Recently, a needle‐like microfiber based on biphasic liquid metal was created. This microfiber can reach the target site simply by puncturing and enable multifunctional sensing. [7] At about the same time, a device amalgamated with living and synthetic components was developed for studying and treating inflammatory skin disease. [8] This device enables real‐time digital updates and potentially adaptive treatment of non‐resolving inflammation, which is enlightening for the new generation of adaptive bioelectronics.
Article
Full-text available
Methods Probes were developed and initial tests were performed. The probes used had electrodes that are far apart, with the assumption that in such cases deeper layers of the cervical tissue are measured. Results Preliminary measurements were performed in a single session on a non-gravid uterus, using as excitation signal a sinusoidal wave with frequency varying from 3 kHz to 100 kHz. Results indicate, as expected, that the magnitude of the impedance is inversely proportional to the frequency, indicating capacitive impedance. Conclusion Preliminary results were very encouraging. However, further measurements must be performed to correlate the impedance to the cervical ripening.
Article
Full-text available
Objective To identify follicle sizes on the day of trigger most likely to yield a mature oocyte following hCG, GnRH agonist (GnRHa), or kisspeptin during IVF treatment. Design Retrospective analysis to determine the size of follicles on day of trigger contributing most to the number of mature oocytes retrieved using generalized linear regression and random forest models applied to data from IVF cycles (2014–2017) in which either hCG, GnRHa, or kisspeptin trigger was used. Setting HCG and GnRHa data were collected at My Duc Hospital, Ho Chi Minh City, Vietnam, and kisspeptin data were collected at Hammersmith Hospital, London, UK. Patients Four hundred and forty nine women aged 18–38 years with antral follicle counts 4–87 were triggered with hCG (n = 161), GnRHa (n = 165), or kisspeptin (n = 173). Main outcome measure Follicle sizes on the day of trigger most likely to yield a mature oocyte. Results Follicles 12–19 mm on the day of trigger contributed the most to the number of oocytes and mature oocytes retrieved. Comparing the tertile of patients with the highest proportion of follicles on the day of trigger 12–19 mm, with the tertile of patients with the lowest proportion within this size range, revealed increases of 4.7 mature oocytes for hCG (P < 0.0001) and 4.9 mature oocytes for GnRHa triggering (P < 0.01). Using simulated follicle size profiles of patients with 20 follicles on the day of trigger, our model predicts that the number of oocytes retrieved would increase from a mean 9.8 (95% prediction limit 9.3–10.3) to 14.8 (95% prediction limit 13.3–16.3) oocytes due to the difference in follicle size profile alone. Conclusion Follicles 12–19 mm on the morning of trigger administration were most likely to yield a mature oocyte following hCG, GnRHa, or kisspeptin.
Article
Full-text available
Cervical mucus plays a vital role in female fertility. Infertility is most important factor arising in reproductive health. It helps in the sperm migration through the female reproductive tract, biochemical and morphological changes to sperm, and sperm egg interaction in the oviduct. The maximum cases of infertility have been found in human population, but they do not know why they cannot conceive. Secretion levels of cervical mucus decide the fertility and infertility in mammals. The cervical glands proliferate under the influence of oestrogen secreted during the follicular stage of the ovarian cycle. The glands become longer as the follicular cycle progresses. The glandular epithelial cells become larger and start to secrete mucus that is initially thick and viscous. This watery cervical mucus helps the sperm to swim into the uterus to fertilize the ovum. It plays role in the protection of the uterine cavity from pathogens and controls survival and migration of sperm cells. At ovulation, oestrogens increase hydration of mucus, which results in watery secretion with low visco-elasticity, allowing sperm cells to penetrate .This review is an attempt to collect relevant knowledge about the structure and production of cervical mucus and draws attention to cervical mucus effect on fertilization.
Article
Full-text available
Unexplained infertility diagnosis is made in the presence of a normal semen analysis when tubal patency and normal ovulatory function are established. Among several potential causes, unexplained infertility could be attributed to vaginal pH and cervical mucus abnormalities. Although the vaginal canal and the cervix generally function as effective barriers to sperm, and although the production of mucus is essential to transport them from the vagina to the uterine cavity, these factors receive little attention in the investigation of couples with unexplained infertility. A substantial reduction in sperm number occurs as they transverse the cervix. From an average of 200 to 300 million sperm deposited in the vagina, only a few hundred achieve proximity to the oocyte. Given this expected high spermatozoa loss, a slight modification in cervical mucus may rapidly transform the cervix into a "hostile" environment, which, together with changes in vaginal environment and cervix structure, may prevent natural conception and be a cause of infertility. In this review, we discuss the physiological role of the vaginal pH and cervical mucus in fertility, and describe several conditions that can render the cervical mucus hostile to sperm and therefore be implicated in the pathophysiology of unexplained infertility.
Article
Full-text available
The application of electrochemical impedance spectroscopy (EIS) has increased dramatically in the past few years due to its ability to elucidate a plethora of physical and electronic properties of electrochemical systems such as diffusion coefficients, electron transfer rate constants, adsorption mechanisms, charge transfer resistances, capacitances and pore sizes. This review provides a short introduction to the fundamental principles of EIS before exploring the many exciting and pertinent analytical applications regarding the numerous methods in biosensing, the application of EIS with graphene based materials and last, the use of EIS with screen printed electrodes.
Article
Full-text available
Structure of human cervical mucus plays a pivotal role in female fertility and protection of reproductive health. Investigation of biochemical and biophysical structure of cervical mucus remains a challenge due to complex structural proteins, high content of oligosaccharides and cyclic variability of its structure. We present the current knowledge on chemical and biophysical features of cervical mucus and regulation of its secretion, relevant clinical observations and underexplored elements. The latter relates to biochemical background of physical properties and antimicrobial activity of cervical mucus, and regulation of its production.
Article
Full-text available
The utility of cervical electrical impedance spectroscopy (EIS) as a diagnostic tool is being investigated in clinical trials. We sought to assess the reliability of two different sizes of tetrapolar probes used in measuring cervical impedance. Cervical transfer impedance was measured at 14 frequencies between 76 and 625 000 Hz from 11 pregnant subjects at term. Repeated measurements were taken with two probes (3 mm and 12 mm diameter) applied softly (approximately 0.7 Newton of force), and firmly (approximately 2.2 Newton) to the surface of the cervix by two observers. The intra-class correlation coefficient (ICC), coefficient of variation (CV) and repeatability standard deviations (SD) were derived from these measurements and compared. Measurements taken by one observer were highly repeatable for both probes as demonstrated by high ICC and low CV values. Probe performance was improved further by firm application. Firm application of the 3 mm probe resulted in ICC values that ranged from 0.936 to 0.986 (p = 0.0001) and CV values between 1.0 and 3.4%. Firm pressure with the 12 mm probe resulted in ICC values that ranged between 0.914 and 0.988 (p = 0.0001) with CV values between 0.7 and 2.1%. In addition, the repeatability SD was low across all frequencies implying that there was low intra-observer variability. Measurements taken by 2 observers with firm application of the 12 mm probe demonstrated moderate reproducibility between 9.8 and 156 kHz, the frequency range in which previous clinical studies have shown predictive association between high cervical resistivity and vaginal delivery: ICC values ranged between 0.528 and 0.638 (p < 0.05), CV values were between 3.3 and 5.2% and reproducibility SD values were also low. In contrast the 3 mm probe demonstrated poor reproducibility at all study frequencies. Measuring cervical resistivity by a single observer with both the 3 and 12 mm probes is highly repeatable whilst inter-observer reproducibility is poor with the 3 mm probe but moderately good when the 12 mm probe is firmly applied to the cervix in the frequency range 9.8 to 156 kHz, consistent with our observations of probe performance in clinical trials.
Article
The purpose of this article is to review the principle concepts in literature concerning the fertile window in patients with normal menstrual cycles. The basic concepts of ovulation are examined as well. The primary emphasis is on an analysis of Brown's theory of ovulation and a look at the basic concepts concerning secretion, the metabolism of follicle-stimulating hormones, and clinical, ultrasound and biochemical study of the follicular development of the fertile window. Also examined are the clinical biomarkers and the different endocrinal metabolites that have been tested in the fertile phase of the cycle. A number of studies are reviewed in which measured concentrations of sex steroid hormones in plasma and urine were shown to have a direct bearing on identifying the fertile period. This knowledge is relevant for different interest groups, particularly couples who are interested in fertility awareness and can benefit by applying currently available technical know-how to detect the fertile window. Couples involved in fertility regulation programs (FRP) who want to prevent pregnancy can benefit as well, as can those who want to pinpoint the most fertile time for becoming pregnant. Other target groups include persons who have no experience with FRP courses, but would like to improve their fertility awareness through a short interview, or couples who are looking for pregnancy options through NaProTechnology programs or have taken family orientation courses.